Literature DB >> 18191904

Selective regulation of neurosteroid biosynthesis in human neuroblastoma cells under hydrogen peroxide-induced oxidative stress condition.

V Schaeffer1, C Patte-Mensah, A Eckert, A G Mensah-Nyagan.   

Abstract

Neurosteroid biosynthesis is demonstrated in many species but key factors interacting with neurosteroidogenesis under pathophysiological conditions are unknown. Hydrogen peroxide (H(2)O(2))-induced oxidative stress is an etiological factor involved in several disorders. We hypothesized that, if neurosteroidogenesis is a pivotal mechanism for nerve cell protection or viability, it might be selectively regulated under oxidative stress condition. To check our hypothesis, we investigated H(2)O(2) effects on neurosteroidogenesis in human neuroblastoma SH-SY5Y cells. Pulse-chase, high performance liquid chromatography and flow-scintillation analyses showed that, along neurosteroidogenic pathways converting pregnenolone into various neurosteroids, only estradiol synthesis selectively decreased in SH-SY5Y cells after H(2)O(2)-treatment. Testosterone conversion into estradiol was also inhibited by H(2)O(2). Real-time reverse transcription-polymerase chain reaction revealed aromatase gene repression in SH-SY5Y cells 12 h after the oxidative stress onset. Consistently, viability assays showed that chronic inhibition of aromatase activity by letrozole killed neuroblastoma cells. A 12-h pretreatment of SH-SY5Y cells with estradiol was protective against H(2)O(2)-induced death. In addition, estradiol was also capable of rescuing markedly neuroblastoma cells from letrozole-evoked death. Altogether, these results suggest that endogenous estradiol formation is pivotal for SH-SY5Y cell viability. Serum deprivation-evoked stress, which also killed SH-SY5Y cells, unaffected neurosteroidogenesis, indicating that inhibitory effect on neuroprotective-neurosteroid estradiol biosynthesis is specific for H(2)O(2)-induced stress. Selective targeting of neurosteroidogenic pathways may therefore constitute an interesting strategy against H(2)O(2)-evoked neurodegenerative processes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18191904     DOI: 10.1016/j.neuroscience.2007.11.032

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  6 in total

1.  Amyloid Beta Peptides Affect Pregnenolone and Pregnenolone Sulfate Levels in PC-12 and SH-SY5Y Cells Depending on Cholesterol.

Authors:  Ozlem Gursoy Calan; Pinar Akan; Aysenur Cataler; Cumhur Dogan; Semra Kocturk
Journal:  Neurochem Res       Date:  2016-03-26       Impact factor: 3.996

2.  Age-related changes in neuroactive steroid levels in 3xTg-AD mice.

Authors:  Donatella Caruso; Anna M Barron; Meghan A Brown; Federico Abbiati; Paloma Carrero; Christian J Pike; Luis M Garcia-Segura; Roberto C Melcangi
Journal:  Neurobiol Aging       Date:  2012-11-02       Impact factor: 4.673

Review 3.  Alzheimer's disease, oestrogen and mitochondria: an ambiguous relationship.

Authors:  Amandine Grimm; Yun-An Lim; Ayikoe Guy Mensah-Nyagan; Jürgen Götz; Anne Eckert
Journal:  Mol Neurobiol       Date:  2012-06-08       Impact factor: 5.590

4.  Comparative Analysis of Gelsemine and Gelsemium sempervirens Activity on Neurosteroid Allopregnanolone Formation in the Spinal Cord and Limbic System.

Authors:  Christine Venard; Naoual Boujedaini; Ayikoe Guy Mensah-Nyagan; Christine Patte-Mensah
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-16       Impact factor: 2.629

5.  Selective regulation of neurosteroid biosynthesis under ketamine-induced apoptosis of cortical neurons in vitro.

Authors:  Jianli Li; Yang Yu; Bei Wang; Honghai Wu; Gai Xue; Yanning Hou
Journal:  Mol Med Rep       Date:  2015-12-23       Impact factor: 2.952

Review 6.  Neurosteroid Metabolites of Gonadal Steroid Hormones in Neuroprotection: Implications for Sex Differences in Neurodegenerative Disease.

Authors:  Ari Loren Mendell; Neil James MacLusky
Journal:  Front Mol Neurosci       Date:  2018-10-05       Impact factor: 5.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.